Skip to content
Independent analysis of NHS open data
PharmaInsight

Octasa 800mg MR gastro-resistant tablets

0105010B0BIAAAS · Gastro-Intestinal System
Data updated May 2026
35,406items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£2,184,794

Net ingredient cost · May 2026

NHSBSA PCA

430,242items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Octasa 800mg MR gastro-resistant tablets: national items dispensed by month

0 19k 38k Jan 2021 Nov 2021 Sep 2022 Jul 2023 May 2024 Mar 2025 May 2026 35,406 Jan 2021: 23k Feb 2021: 21k Mar 2021: 24k Apr 2021: 23k May 2021: 22k Jun 2021: 24k Jul 2021: 24k Aug 2021: 23k Sep 2021: 24k Oct 2021: 24k Nov 2021: 25k Dec 2021: 27k Jan 2022: 26k Feb 2022: 24k Mar 2022: 29k Apr 2022: 28k May 2022: 29k Jun 2022: 29k Jul 2022: 30k Aug 2022: 30k Sep 2022: 30k Oct 2022: 30k Nov 2022: 31k Dec 2022: 31k Jan 2023: 31k Feb 2023: 28k Mar 2023: 32k Apr 2023: 29k May 2023: 31k Jun 2023: 32k Jul 2023: 32k Aug 2023: 32k Sep 2023: 32k Oct 2023: 32k Nov 2023: 33k Dec 2023: 33k Jan 2024: 34k Feb 2024: 32k Mar 2024: 32k Apr 2024: 33k May 2024: 34k Jun 2024: 32k Jul 2024: 35k Aug 2024: 34k Sep 2024: 33k Oct 2024: 35k Nov 2024: 34k Dec 2024: 35k Jan 2025: 36k Feb 2025: 32k Mar 2025: 34k Apr 2025: 35k May 2025: 36k Jun 2025: 35k Jul 2025: 38k Aug 2025: 34k Sep 2025: 36k Oct 2025: 37k Nov 2025: 34k Dec 2025: 38k Jan 2026: 36k Feb 2026: 33k Mar 2026: 37k Apr 2026: 36k May 2026: 35k

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Mesalazine (Systemic). See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).